Several studies have suggested that activation of the UPR in HCV infected cells contributes to pathogenesis, including through increased liver fibrosis via transforming growth factor β1 (TGF-β1) induction (78) and development of insulin resistance and type 2 diabetes mellitus (79, 80). This evidence concerns the gene TGFB1 and Hepatic fibrosis.